samedan logo
 
 
 
spacer
home > pmps > summer 2018 > the next generation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Next Generation

Efforts to comply with tightening regulatory requirements pertaining to serialisation and track-and-trace capabilities have generated new opportunities to fully digitise the pharmaceutical cold chain, thereby creating the ability to monitor products moving from manufacturers through distribution centres, wholesalers, and logistics partners through last mile distribution, thus improving operational efficiencies and driving more accurate decision-making.

The pharma chain is one of the most complex supply chains globally, given the nature of the industry, the scope and size of the companies that dominate it, and their extended networks of logistics partners. However, it has historically been unwieldy and resistant to transformation.

Over the past two years, the way consumers and regulators have approached the pharma industry has changed significantly, which has pushed pharma enterprises towards an inflection point. Growing consumer expectations, an increase in various multichannel regulatory issues and scrutiny from regulators, and a fluctuation in mergers and acquisition activity have put the supply chain under more pressure than ever before to be redesigned. These pressures grow even more complex and intense across globally distributed organisations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Ada Palmadottir is Business Development Director at Controlant. With more than 20 years in pharmacy, management, and technology, Ada has extensive international experience in sales, operations, and marketing, specifically in the areas of product, vertical alliance sales, and partnerships related to pharmaceutical products. She is a licensed and experienced pharmacist and earned a Master of Pharmacy from the University of Iceland and a Master of Business Administration from the Norwegian School of Management in Oslo. Ada has been working with Controlantís Cold Chain as a Service solutions for the last six years.
spacer
Ada Palmadottir
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT and Science 37 Partner to Deliver High-Quality Data during Virtual Trials

ERT, the global leader in clinical endpoint data collection and Science 37, the leader in decentralized clinical trials, today announced a partnership enabling ERTís Cardiac Safety, Respiratory, and Imaging solutions to be incorporated into the Science 37 virtual, or decentralized clinical trial offering. The combined solution significantly improves data quality while dramatically reducing patient burden.
More info >>

White Papers

The BioPharmaSpec ApproachĒ: Mass Spectrometry Based Host Cell Protein Identification and Quantitation

BioPharmaSpec

1. Introduction As part of the development of any biopharmaceutical product, the impurities present must be examined, minimized and where possible characterized (1). These impurities fall into two broad categories: product-related impurities (derived specifically from the drug product itself) and process-related impurities (derived from material associated with the production, processing or purification of the sample). Host cell proteins (HCPs) are process-related impurities that require specific analysis due to the multitude of naturally occurring proteins expressed in the production cell line.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement